Patients with Atrial Fibrillation deemed high risk following analysis had five times as many cardiovascular events as low-risk cluster
Procedure used to treat children born with heart conditions may provide a new treatment opportunity
Team led by Dr Katja Gehmlich wins half a million pound grant to further understanding of condition called hypertrophic cardiomyopathy
Birmingham researchers are working with community groups to help boost screening and diagnosis of a rare genetic condition in under-represented groups.
Partnership agreement with Acticor Biotech sees first patient treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction.
Taking testosterone may increase the risk of atrial fibrillation in individuals with an existing predisposition
Birmingham researchers have been celebrated for their breakthrough work in thrombosis.
Males win 88% of awards named after men, and 53% of prizes named after women
Discovery means potential protective treatments could be developed to block thrombosis from developing following vaccination.
Helen Matthews, Head of Operations at the Institute of Clinical Sciences, University of Birmingham, has been awarded the Vitae ICE Award for work on menopause.